VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

Abstract

Treatment of patients with mild to moderate UC, not responding to conventional therapy, with VSL#3 resulted in a combined induction of remission/response rate of 77% with no adverse events. At least some of the bacterial species incorporated in the probiotic product reached the target site in amounts that could be detected.